Drugmaker Apotex Files for Canada IPO Showing Revenue Jump (2)

Canadian generic drugmaker Apotex Health Corp. filed for an initial public offering in Toronto, it said in a statement on Thursday.

The share sale will include the company’s treasury shares and a secondary offering including holdings of controlling shareholder SK Capital Partners. Apotex applied to list on the Toronto Stock Exchange under the symbol APTX.

In February, Bloomberg News reported the Toronto-based firm is seeking to raise between C$750 million ($544 million) and C$1 billion in the offering. The top of that range would make it Canada’s largest market debut since Definity Financial Corp. raised about C$1.6 billion in ...